GUSELKUMAB (Tremfya)
Clinical Indication
For treatment of adult patients with moderate to severely active Crohn's disease or Ulcerative Colitis
Date of classification
June 2025
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.